Geneesmiddelenbeleid

This procedure involves a written consultation regarding the pharmaceutical policy of the Netherlands. It aims to evaluate and refine how medicines are managed, regulated, and accessed to ensure healthcare sustainability and patient safety. This affects healthcare providers, pharmaceutical companies, and patients by potentially changing how medications are priced, procured, or approved for use.